Skip to search formSkip to main contentSkip to account menu

Myeloablative Chemotherapy

High-dose chemotherapy that kills cells in the bone marrow, including cancer cells. It lowers the number of normal blood-forming cells in the bone… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major
Patients with thalassemia in developing countries have limited access to safe transfusions, regular medical care and chelation… 
Review
2013
Review
2013
Reduced intensity allogeneic hematopoietic transplantation is an established standard of care for treatment of older patients with acute myeloid leukemia.
2009
2009
Management and outcome of stage 3 neuroblastoma.
Review
2009
Review
2009
Reduced-intensity conditioning and umbilical cord blood transplantation in adults
Reduced-intensity conditioning (RIC) preparative regimens are now widely used in umbilical cord blood (UCB) transplantation… 
Review
2008
Review
2008
Reduced intensity and non‐myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non‐malignant diseases
Allogeneic hematopoietic stem cell transplant (AlloSCT) from related or unrelated histocompatible donors has been well… 
2008
2008
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: Outcome compared with conventional chemotherapy: A report from the…
Children and adolescents with malignant astrocytomas recurring after initial treatment have a dismal prognosis, with only rare… 
Highly Cited
2002
Highly Cited
2002
Treatment of high‐risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co‐infusion of T cell‐depleted haematopoietic stem cells and culture‐expanded marrow mesenchymal stem…
Summary.  A 20‐year‐old woman with high‐risk acute myelogenous leukaemia was transplanted with granulocyte colony stimulating… 
Highly Cited
2002
Highly Cited
2002
Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem…
2002
2002
Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignancies
Abstract. Standard treatment regimens for haematological malignancies include myeloablative chemoradiotherapy and subsequent… 
Review
1989
Review
1989
High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease.
Twenty three patients with Hodgkin's disease were treated with BCNU (carmustine), etoposide, and cyclophosphamide at doses of 450… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)